Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients.
Related Articles
Impact Factor
Are macrophages the bad guys in Hodgkin lymphoma?
Senza categoria
N E W S R O U N D
Senza categoria
Leave a Reply